Clinical Trial Update: Evaluation of the Efficacy and Safety of Rosuvastatin 5 mg Versus Pravastatin 40 mg and Atorvastatin 10 mg in Type IIa and IIb Hypercholesterolaemic Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing rosuvastatin 5 mg with pravastatin 40 mg and atorvastatin 10 mg in patients with Type IIa/IIb hypercholesterolemia; results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Pravastatin (pravastatin)
• Rosuvastatin (rosuvastatin)
• atorvastatin (atorvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Type IIa and IIb Hypercholesterolaemia | Phase 4 | Status: COMPLETED | Results posted: 2010-09-17